Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7.3 Mln
Feb 18 (Reuters) - Initiator Pharma A/S INIT.ST :
* INITIATOR PHARMA: YEAR END REPORT 2021
* Q4 NET REVENUES WERE TDKK 0 (0)
* Q4 OPERATING LOSS, EBIT WAS TDKK -7 280 (-2 069)
Source text for Eikon: ID:nMFN6DdYKc
Further company coverage: INIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD